New Non-Executive Director

3 September 2013

New Non-Executive Director

DCC plc, the sales, marketing, distribution and business support services group, announces the appointment of Dr. Pam Kirby as a non-executive Director, with effect from 3 September 2013.

Dr. Kirby has extensive knowledge of the international healthcare sector, having worked in the pharmaceutical industry for more than twenty five years. She held senior UK and global management positions in AstraZeneca PLC and in F. Hoffman-La Roche Ltd., where she was Director of Global Strategic Marketing. Dr. Kirby is also a former CEO of Quintiles Transnational Corporation in the USA, the leading global provider of biopharmaceutical development and commercial outsourcing services.

Dr. Kirby currently serves as Chairman of Scynexis Inc and as a non-executive director of Victrex plc, Smith and Nephew plc and Informa plc. She was also previously a non-executive director of Novo Nordisk A/S and of Curalogic A/S.

There are no other details to be disclosed under Listing Rule 9.6.13 (1) to (6) of the Listing Rules of the Financial Conduct Authority in respect of Dr. Kirby.

The Chairman of DCC plc, Michael Buckley, said today:

"I warmly welcome Pam to the Board. Her extensive international business experience and her particular knowledge of the healthcare sector make her an excellent addition to the Board."

For reference:

Stephen Casey

Investor Relations Manager

Tel: +353 1 2799 400

Email: [email protected]

Web: www.dcc.ie

About DCC plc

DCC plc is a sales, marketing, distribution and business support services group organised and managed across five divisions - DCC Energy, DCC SerCom, DCC Healthcare, DCC Environmental and DCC Food & Beverage. In its last financial year ended 31 March 2013, DCC generated sales of £10.6 billion and operating profit of £187 million. DCC currently employs almost 10,000 people and its shares are listed on the London Stock Exchange under Support Services.